We are live on ! Find out more
EMMA

Emmaus Life Sciences, Inc. Common Stock
EMMA

Delisted

EMMA was delisted on the 10th of September, 2019.

Back to rankings

1 hedge funds and large institutions have $55K invested in Emmaus Life Sciences, Inc. Common Stock in 2020 Q3 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
1
Holders Change
+1
Holders Change %
–
% of All Funds
0.02%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
DC
Diametric Capital
Massachusetts
+$55K

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
DC
1
Diametric Capital
Massachusetts
$55K +$55K +57,034 New

EMMA Hedge Fund Activity: Q3 2020 in Review

1 of the 4,956 institutional investors tracked by Wall St. Rank reported a position in Emmaus Life Sciences, Inc. Common Stock (EMMA) for Q3 2020, worth a combined $55K.

Buyers outnumbered sellers: 1 fund opened new EMMA positions and 0 closed out — a net gain of 1 holder — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Diametric Capital, opening a new position worth an estimated $55K.

  • 1 institutional investor held Emmaus Life Sciences, Inc. Common Stock (EMMA) as of Q3 2020, up from 0 in Q2 2020.
  • Funds reported $55K of Emmaus Life Sciences, Inc. Common Stock stock for Q3 2020.
  • 1 fund opened new Emmaus Life Sciences, Inc. Common Stock positions in Q3 2020 and 0 closed out, a net change of +1 holder.
  • The largest Emmaus Life Sciences, Inc. Common Stock buyer in Q3 2020 was Diametric Capital, an estimated $55K added.

Based on aggregated 13F filings for Q3 2020.